What are you looking for?

Need help finding what you are looking for? Contact Us

Compare

Free Samples

Home Market Research Reports Pharmaceutical

Respiratory

PUBLISHER: 360iResearch | PRODUCT CODE: 1589191

PUBLISHER: 360iResearch | PRODUCT CODE: 1589191

Cough Suppressant Drugs Market by Disease Type (Dry Cough, Wet Cough), Drug Type (Benzonatate, Butamirate, Codeine), Age Group, Dosage Form, Distribution Channel - Global Forecast 2025-2030

PUBLISHED: October 31, 2024

PAGES: 181 Pages

DELIVERY TIME: 1-2 business days

ADD TO COMPARE

SELECT AN OPTION

List of Tables

The Cough Suppressant Drugs Market was valued at USD 1.98 billion in 2023, expected to reach USD 2.07 billion in 2024, and is projected to grow at a CAGR of 4.63%, to USD 2.72 billion by 2030.

Cough suppressant drugs, commonly used to alleviate coughing, are a significant segment within the broader pharmaceutical market. Primarily, these drugs include both prescription and over-the-counter medications. The necessity for cough suppressants is driven by the prevalence of respiratory infections, allergies, and ailments like chronic obstructive pulmonary disorder, significantly enhancing their application for symptomatic relief. End-use extends across hospitals, clinics, and even households. Influencing growth factors include the increasing incidence of respiratory diseases and rising consumer awareness towards self-medication. The influx of advanced drug formulations and an emphasis on pediatric cough suppressants further propels the market. Lately, there has been a surge in demand due to a heightened focus on health post-COVID-19, presenting potential opportunities for firms to innovate in non-drowsy formulas and herbal, side-effect-free variants to capture health-conscious consumers.

KEY MARKET STATISTICS
Base Year [2023]	USD 1.98 billion
Estimated Year [2024]	USD 2.07 billion
Forecast Year [2030]	USD 2.72 billion
CAGR (%)	4.63%

On the flip side, limitations challenging growth include stringent regulatory standards and side-effect concerns associated with cough suppressants, which may impede market penetration. Additionally, the misinterpretation and misuse of these medications among consumers can lead to hesitancy in adoption. To mitigate these challenges, research and development can focus on improving the safety profile and efficacy of these drugs. Exploring the natural ingredient spectrum, broadening formulations to include immuno-boosting properties, and innovating in drug delivery systems such as lozenges or fast-acting sprays are promising areas. Overall, the market remains moderately competitive, with a tilt towards consolidation as leading companies invest in strategic partnerships and acquisitions to broaden their product lines and improve distribution networks. Understanding local regulations and consumer behavior nuances remain pivotal for companies aiming to expand their footprint. The market's nature suggests steady growth potential, driven by technological advancements, shifting consumer preferences, and a continual need for effective respiratory ailment management solutions.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cough Suppressant Drugs Market

The Cough Suppressant Drugs Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

Market Drivers
- Increase in the cases of chronic lung disorders
- Surge in the number of smokers globally
- Emergence in vulnerable indoor as well as outdoor allergens
Market Restraints
- Huge cost associated with treatment and shortage of skilled labor
Market Opportunities
- Development of novel therapies and drugs
- Government initiatives for advanced healthcare infrastructures
Market Challenges
- Side impacts of cough suppressant drugs

Porter's Five Forces: A Strategic Tool for Navigating the Cough Suppressant Drugs Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cough Suppressant Drugs Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cough Suppressant Drugs Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cough Suppressant Drugs Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cough Suppressant Drugs Market

A detailed market share analysis in the Cough Suppressant Drugs Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cough Suppressant Drugs Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cough Suppressant Drugs Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cough Suppressant Drugs Market

A strategic analysis of the Cough Suppressant Drugs Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cough Suppressant Drugs Market, highlighting leading vendors and their innovative profiles. These include Acella Pharmaceuticals, LLC, Alvizia Healthcare Private Limited, Amneal Pharmaceuticals, Inc., Athens Labs Ltd., Aurobindo Pharma Limited, Aytu BioScience, Inc., Bayer AG, GlaxoSmithKline PLC, Mayne Pharma, Inc., Pfizer Inc., Solace Biotech Ltd., Taro Pharmaceutical Industries, Tris Pharma, Inc., Vernalis PLC, and Zenes Biotech Pvt. Ltd..

Market Segmentation & Coverage

This research report categorizes the Cough Suppressant Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

Based on Disease Type, market is studied across Dry Cough and Wet Cough.
Based on Drug Type, market is studied across Benzonatate, Butamirate, Codeine, Dextromethorphan, Noscapine, and Pholcodine.
Based on Age Group, market is studied across Adult and Pediatric.
Based on Dosage Form, market is studied across Syrup and Tablet.
Based on Distribution Channel, market is studied across Hospital, Online Pharmacy, and Retail Drug Store.
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Product Code: MRR-4311CE1A33E4

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Increase in the cases of chronic lung disorders
  - 5.1.1.2. Surge in the number of smokers globally
  - 5.1.1.3. Emergence in vulnerable indoor as well as outdoor allergens
- 5.1.2. Restraints
  - 5.1.2.1. Huge cost associated with treatment and shortage of skilled labor
- 5.1.3. Opportunities
  - 5.1.3.1. Development of novel therapies and drugs
  - 5.1.3.2. Government initiatives for advanced healthcare infrastructures
- 5.1.4. Challenges
  - 5.1.4.1. Side impacts of cough suppressant drugs
5.2. Market Segmentation Analysis
5.3. Porter's Five Forces Analysis
- 5.3.1. Threat of New Entrants
- 5.3.2. Threat of Substitutes
- 5.3.3. Bargaining Power of Customers
- 5.3.4. Bargaining Power of Suppliers
- 5.3.5. Industry Rivalry
5.4. PESTLE Analysis
- 5.4.1. Political
- 5.4.2. Economic
- 5.4.3. Social
- 5.4.4. Technological
- 5.4.5. Legal
- 5.4.6. Environmental

6. Cough Suppressant Drugs Market, by Disease Type

6.1. Introduction
6.2. Dry Cough
6.3. Wet Cough

7. Cough Suppressant Drugs Market, by Drug Type

7.1. Introduction
7.2. Benzonatate
7.3. Butamirate
7.4. Codeine
7.5. Dextromethorphan
7.6. Noscapine
7.7. Pholcodine

8. Cough Suppressant Drugs Market, by Age Group

8.1. Introduction
8.2. Adult
8.3. Pediatric

9. Cough Suppressant Drugs Market, by Dosage Form

9.1. Introduction
9.2. Syrup
9.3. Tablet

10. Cough Suppressant Drugs Market, by Distribution Channel

10.1. Introduction
10.2. Hospital
10.3. Online Pharmacy
10.4. Retail Drug Store

11. Americas Cough Suppressant Drugs Market

11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States

12. Asia-Pacific Cough Suppressant Drugs Market

12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam

13. Europe, Middle East & Africa Cough Suppressant Drugs Market

13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom

14. Competitive Landscape

14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
14.4. Strategy Analysis & Recommendation

Companies Mentioned

1. Acella Pharmaceuticals, LLC
2. Alvizia Healthcare Private Limited
3. Amneal Pharmaceuticals, Inc.
4. Athens Labs Ltd.
5. Aurobindo Pharma Limited
6. Aytu BioScience, Inc.
7. Bayer AG
8. GlaxoSmithKline PLC
9. Mayne Pharma, Inc.
10. Pfizer Inc.
11. Solace Biotech Ltd.
12. Taro Pharmaceutical Industries
13. Tris Pharma, Inc.
14. Vernalis PLC
15. Zenes Biotech Pvt. Ltd.

Product Code: MRR-4311CE1A33E4

LIST OF FIGURES

FIGURE 1. COUGH SUPPRESSANT DRUGS MARKET RESEARCH PROCESS
FIGURE 2. COUGH SUPPRESSANT DRUGS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
FIGURE 11. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2023 VS 2030 (%)
FIGURE 13. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 15. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 19. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 24. COUGH SUPPRESSANT DRUGS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 25. COUGH SUPPRESSANT DRUGS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

TABLE 1. COUGH SUPPRESSANT DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. COUGH SUPPRESSANT DRUGS MARKET DYNAMICS
TABLE 7. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRY COUGH, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY WET COUGH, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY BENZONATATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY BUTAMIRATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CODEINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DEXTROMETHORPHAN, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY NOSCAPINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PHOLCODINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY RETAIL DRUG STORE, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 43. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 44. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 45. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 46. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 47. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 48. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 49. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 50. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 51. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 52. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 59. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 61. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 62. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 63. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 64. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 65. AUSTRALIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 66. AUSTRALIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 67. AUSTRALIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 68. AUSTRALIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 69. AUSTRALIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 70. CHINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 71. CHINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 72. CHINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 73. CHINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 74. CHINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 75. INDIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 76. INDIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 77. INDIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 78. INDIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 79. INDIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 80. INDONESIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 81. INDONESIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 82. INDONESIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 83. INDONESIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 84. INDONESIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 85. JAPAN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 86. JAPAN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 87. JAPAN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 88. JAPAN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 89. JAPAN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 90. MALAYSIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 91. MALAYSIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 92. MALAYSIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 93. MALAYSIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 94. MALAYSIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 95. PHILIPPINES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 96. PHILIPPINES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 97. PHILIPPINES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 98. PHILIPPINES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 99. PHILIPPINES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 100. SINGAPORE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 101. SINGAPORE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 102. SINGAPORE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 103. SINGAPORE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 104. SINGAPORE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 105. SOUTH KOREA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 106. SOUTH KOREA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 107. SOUTH KOREA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 108. SOUTH KOREA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 109. SOUTH KOREA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 110. TAIWAN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 111. TAIWAN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 112. TAIWAN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 113. TAIWAN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 114. TAIWAN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 115. THAILAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 116. THAILAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 117. THAILAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 118. THAILAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 119. THAILAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 120. VIETNAM COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 121. VIETNAM COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 122. VIETNAM COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 123. VIETNAM COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 124. VIETNAM COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 131. DENMARK COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 132. DENMARK COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 133. DENMARK COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 134. DENMARK COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 135. DENMARK COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 136. EGYPT COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 137. EGYPT COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 138. EGYPT COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 139. EGYPT COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 140. EGYPT COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 141. FINLAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 142. FINLAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 143. FINLAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 144. FINLAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 145. FINLAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 146. FRANCE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 147. FRANCE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 148. FRANCE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 149. FRANCE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 150. FRANCE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 151. GERMANY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 152. GERMANY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 153. GERMANY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 154. GERMANY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 155. GERMANY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 156. ISRAEL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 157. ISRAEL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 158. ISRAEL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 159. ISRAEL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 160. ISRAEL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 161. ITALY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 162. ITALY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 163. ITALY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 164. ITALY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 165. ITALY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 166. NETHERLANDS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 167. NETHERLANDS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 168. NETHERLANDS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 169. NETHERLANDS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 170. NETHERLANDS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 171. NIGERIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 172. NIGERIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 173. NIGERIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 174. NIGERIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 175. NIGERIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 176. NORWAY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 177. NORWAY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 178. NORWAY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 179. NORWAY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 180. NORWAY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 181. POLAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 182. POLAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 183. POLAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 184. POLAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 185. POLAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 186. QATAR COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 187. QATAR COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 188. QATAR COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 189. QATAR COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 190. QATAR COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 195. RUSSIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 196. SAUDI ARABIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 198. SAUDI ARABIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 200. SAUDI ARABIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 204. SOUTH AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 206. SPAIN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 207. SPAIN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 208. SPAIN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 209. SPAIN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 210. SPAIN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 211. SWEDEN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 212. SWEDEN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 213. SWEDEN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 214. SWEDEN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 215. SWEDEN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 216. SWITZERLAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 217. SWITZERLAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 218. SWITZERLAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 219. SWITZERLAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 220. SWITZERLAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 221. TURKEY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 222. TURKEY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 223. TURKEY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 224. TURKEY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 225. TURKEY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 232. UNITED KINGDOM COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 234. UNITED KINGDOM COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 236. COUGH SUPPRESSANT DRUGS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 237. COUGH SUPPRESSANT DRUGS MARKET, FPNV POSITIONING MATRIX, 2023